“Serum Adiponectin As a Diagnostic Marker of Early Renal Dysfunction in Patients With Hypertension and Type 2 Diabetes”. 2026. Journal of Medical Sciences 21 (1): 22-28. https://doi.org/10.51984/18dd9796.